Hormone therapy increases frequency of abnormal mammograms, breast biopsies

Hormone therapy use remains common among women beginning menopause, according to background information in the article. “For women with a uterus considering combined estrogen plus progestin use, identified breast cancer issues represent a concern,” the authors write.

Rowan T. Chlebowski, M.D., Ph.D., of the Los Angeles Biomedical Research Institute at Harbor–UCLA Medical Center, and colleagues studied 16,608 post-menopausal women who participated in the Women’s Health Initiative (WHI) clinical trial, beginning in 1993 through 1998.

A total of 8,506 women were randomly assigned to receive a combination of estrogen (0.625 milligrams of conjugated equine estrogens per day) plus progesterone (2.5 milligrams of medroxyprogesterone acetate per day), while 8,102 took a placebo. Each woman received a mammogram and breast examination yearly, with biopsies performed based on physicians’ clinical judgment.

During the 5.6 years of the study, 199 women in the combined hormone group and 150 women in the placebo group developed breast cancer. Mammograms with abnormal results were more common among women taking hormones than among women taking placebo (35 percent vs. 23 percent); women taking hormones had a 4 percent greater risk of having a mammogram with abnormalities after one year and an 11 percent greater risk after five years.

Breast biopsies also were more common among women taking hormones than among those assigned to placebo (10 percent vs. 6.1 percent). “Although breast cancers were significantly increased and were diagnosed at higher stages in the combined hormone group, biopsies in that group less frequently diagnosed cancer (14.8 percent vs. 19.6 percent),” the authors write.

“After discontinuation of combined hormone therapy, its adverse effect on mammograms modulated but remained significantly different from that of placebo for at least 12 months,” they continue.

Use of combined hormones increases breast density, which increases the risk of breast cancer and may also delay diagnosis, the authors note. However, breast density was not measured in the current study.

Source: JAMA and Archives Journals

Higher education associated with greater gains in mortality reduction from common cancers
Deaths due to the four most common cancers—lung, colorectal, prostate, and breast—have dropped substantially in the United States from 1993 to 2001 in working-aged individuals. However, not all Americans are equally likely to benefit from those gains. A study published in the July 8 online issue of the Journal of the National Cancer Institute shows that more highly educated individuals had mortality reductions in nearly all of these cancers, while less educated individuals had a mortality reduction in only one of the cancer types.
Researchers show antibody to breast cancer-secreted protein blocks metastasis
Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have made a key discovery about the mechanism of breast cancer metastasis, the process by which cancer spreads. Focusing on a gene dubbed "Dachshund," or DACH1, they are beginning to pinpoint new therapeutic targets to halt the spread of cancer.
Overweight, insulin resistant women at greater risk of advanced breast cancer diagnosis, says study
Women who have risk factors commonly associated with Type 2 diabetes also have much greater odds of being diagnosed with an advanced breast cancer, according to research to be presented today.
Treatment delays result in poor outcomes for men with breast cancer
Men who develop breast cancer are often not treated until the disease has spread to the point that treatment becomes difficult, new results show.
Analysis of cancer incidence, mortality and survival combined reveals encouraging European trends
The first research to look at recent trends in European cancer incidence, mortality and survival together has shown that cancer prevention and management in Europe is moving in the right direction. However, the research reveals that variations between countries in policies for mass screening, access to health care and treatment are reflected in the different cancer rates.
3-D mammograms, cameras may improve breast exams
(AP) -- Remember peeking through a View-Master? Scientists are using the same concept behind the classic kids' toy to try to see mammograms in 3-D. The goal: A better way to check for breast cancer in women with breasts too dense for today's mammograms to give a clear picture.
Pregnancy may help protect against bladder cancer
Pregnancy seems to confer some protection against bladder cancer in mice, scientists have found. Female mice that had never become pregnant had approximately 15 times as much cancer in their bladders as their counterparts that had become pregnant, according to new findings by investigators at the University of Rochester Medical Center.
Symptom screening plus a simple blood test improves early detection of ovarian cancer
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer – abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating – when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online in CANCER.

Hormone therapy increases frequency of abnormal mammograms, breast biopsies

Related stories:

News discussion: